Meclizine
Back to searchMolecule Structure
Scientific Name
Meclizine
Description of the Drug
Meclizine is a histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00737
http://www.drugbank.ca/drugs/DB00737
Brand Name(s)
Not Available
Company Owner(s)
Invagen Pharmaceuticals Inc, Cm Bundy Co, Kv Pharmaceutical Co, Watson Laboratories Inc, Nexgen Pharma Inc, Amneal Pharmaceuticals Of New York Llc, Anabolic Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Udl Laboratories Inc, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4649 | ||
PharmGKB | PA450338 | ||
Human Metabolome Database | HMDB0014875 | ||
DrugBank | DB00737 | ||
PubChem: Thomson Pharma | 14805236 | ||
PubChem | 4034 | ||
Mcule | MCULE-7463916552 | ||
LINCS | LSM-1607 | ||
Nikkaji | J6.532C | ||
BindingDB | 81467 | ||
EPA CompTox Dashboard | DTXSID0023242 | ||
DrugCentral | 1649 | ||
Brenda | 243513 | ||
Guide to Pharmacology | 2757 | ||
rxnorm | MECLIZINE HYDROCHLORIDE | MECLIZINE | ANTIVERT |
KEGG Ligand | C07116 | ||
ChEBI | 6709 |